HK793A - Antibiotics - Google Patents

Antibiotics

Info

Publication number
HK793A
HK793A HK7/93A HK793A HK793A HK 793 A HK793 A HK 793A HK 7/93 A HK7/93 A HK 7/93A HK 793 A HK793 A HK 793A HK 793 A HK793 A HK 793A
Authority
HK
Hong Kong
Prior art keywords
bbm
antibiotics
hydrolysis
esperamicin
see
Prior art date
Application number
HK7/93A
Other languages
English (en)
Inventor
Golik Jerzy
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HK793A publication Critical patent/HK793A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
HK7/93A 1985-08-27 1993-01-07 Antibiotics HK793A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77033585A 1985-08-27 1985-08-27

Publications (1)

Publication Number Publication Date
HK793A true HK793A (en) 1993-01-15

Family

ID=25088206

Family Applications (1)

Application Number Title Priority Date Filing Date
HK7/93A HK793A (en) 1985-08-27 1993-01-07 Antibiotics

Country Status (26)

Country Link
JP (2) JPH0733393B2 (enExample)
KR (1) KR920010226B1 (enExample)
AT (1) AT392971B (enExample)
AU (1) AU604464B2 (enExample)
BE (1) BE905332A (enExample)
CA (1) CA1307256C (enExample)
CH (1) CH668598A5 (enExample)
CY (1) CY1676A (enExample)
DE (1) DE3629052C2 (enExample)
DK (1) DK170671B1 (enExample)
ES (1) ES2002728A6 (enExample)
FI (1) FI83422C (enExample)
FR (1) FR2586686B1 (enExample)
GB (1) GB2179649A (enExample)
GR (1) GR862160B (enExample)
HK (1) HK793A (enExample)
HU (1) HU197915B (enExample)
IE (1) IE59204B1 (enExample)
IL (1) IL79519A0 (enExample)
IT (1) IT1229176B (enExample)
LU (1) LU86562A1 (enExample)
NL (1) NL8602165A (enExample)
PT (1) PT83261B (enExample)
SE (2) SE469632B (enExample)
SG (1) SG109692G (enExample)
ZA (1) ZA865796B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3752355T2 (de) * 1987-01-30 2002-12-05 American Cyanamid Co., Wayne Dihydroderivate der Antibiotika vom Typ LL-E33288
US4916065A (en) * 1988-06-10 1990-04-10 Bristol-Myers Company BU-3420T Antitumor antibiotic
US5028536A (en) * 1989-03-15 1991-07-02 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41339
US5086045A (en) * 1989-03-15 1992-02-04 Bristol-Myers Squibb Company Antitumor antibiotic
CA2027601A1 (en) * 1989-11-06 1991-05-07 Koko Sugawara Antitumor antibiotic bu-3983t
CA2039789A1 (en) * 1990-04-27 1991-10-28 Samuel J. Danishefsky Calicheamicinone, derivatives and analogs thereof and methods of making the same
US5116845A (en) * 1990-05-04 1992-05-26 Bristol-Myers Company BU-3420T antitumor antibiotic
US5264586A (en) * 1991-07-17 1993-11-23 The Scripps Research Institute Analogs of calicheamicin gamma1I, method of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3148023A1 (de) * 1981-12-04 1983-06-09 Rudolf Dipl.-Ing. 8901 Oberottmarshausen Fischer Heizungskessel fuer heisse rauchgase
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora
JPS606194A (ja) * 1983-06-23 1985-01-12 Meiji Seika Kaisha Ltd 新規抗生物質ｓｆ−２２８８及びその製造法
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production

Also Published As

Publication number Publication date
IE59204B1 (en) 1994-01-26
FI863405L (fi) 1987-02-28
ATA231786A (de) 1990-12-15
SE8603597L (sv) 1987-02-28
NL8602165A (nl) 1987-03-16
GB8620118D0 (en) 1986-10-01
SE8603597D0 (sv) 1986-08-26
HU197915B (en) 1989-06-28
FI83422B (fi) 1991-03-28
BE905332A (fr) 1987-02-26
PT83261A (en) 1986-09-01
KR920010226B1 (ko) 1992-11-21
FR2586686B1 (fr) 1990-02-02
HUT44035A (en) 1988-01-28
IE862280L (en) 1987-02-27
GB2179649B (enExample) 1989-10-25
PT83261B (pt) 1989-05-12
JPH0733393B2 (ja) 1995-04-12
IT1229176B (it) 1991-07-23
DE3629052C2 (de) 1995-09-28
CH668598A5 (de) 1989-01-13
FI83422C (fi) 1991-07-10
SG109692G (en) 1992-12-24
IL79519A0 (en) 1986-10-31
ES2002728A6 (es) 1988-10-01
JPS62116589A (ja) 1987-05-28
AU604464B2 (en) 1990-12-20
ZA865796B (en) 1987-04-29
SE469632B (sv) 1993-08-09
CY1676A (en) 1993-10-10
SE9200428L (sv) 1993-08-14
JPH07233186A (ja) 1995-09-05
IT8621527A0 (it) 1986-08-26
AT392971B (de) 1991-07-25
DK406086A (da) 1987-02-28
GR862160B (en) 1986-12-31
FI863405A0 (fi) 1986-08-22
FR2586686A1 (fr) 1987-03-06
LU86562A1 (fr) 1987-03-06
DK406086D0 (da) 1986-08-26
CA1307256C (en) 1992-09-08
DK170671B1 (da) 1995-11-27
KR870002269A (ko) 1987-03-30
SE9200428D0 (sv) 1992-02-13
GB2179649A (en) 1987-03-11
AU6175186A (en) 1987-03-05
DE3629052A1 (de) 1987-05-07

Similar Documents

Publication Publication Date Title
AU580184B2 (en) Dual mode I.V. infusion device
AU633413B2 (en) Improved trocar with valve
AU624076B2 (en) Multi-luminal catheter, multi-luminal catheter assembly and production thereof
AU569624B2 (en) Avermectin and milbermycin 13-keto, 13-imino and 13-amino derivatives
AU582584B2 (en) N-acetyl-neurominic acid expectorants
AU6878287A (en) High molecular compounds having amino groups, and their utilization
AU586034B2 (en) Benzothiazolones, and their production and use
AU2071988A (en) Haloarylnitrile degrading gene, its use, and cells containing the gene
AU574921B2 (en) I.v. with float valve
AU7048791A (en) Promotion of high specificity molecular assembly
AU1466388A (en) Low molecular weight heparins of regular structure, their preparation and their biological uses
AU7668187A (en) N-phenylbutenamides with pharmaceutical properties
EP0215662A3 (en) Anti-tumor protease preparations
EP0194833A3 (en) Erythromycin derivatives
AU1740488A (en) Phenol derivatives, their production and use
AU2156588A (en) Tetrahydroindazolyl-benzoxazines, their production and use
AU6910991A (en) The scl gene, and the encoded hematopoietic factor
HUT44035A (en) Process for producing new antibiotic bbm-1675 c and d of antitumor effect and pharmaceutical preparations containing these
AU5920786A (en) 1,8-bridged 4-quinolone-3-carboxylic acids and derivatives
AU550414B2 (en) Plasmid p sg 2 from streptomyces ghanaensis atcc 14672
AU599133B2 (en) Novel substituted (4.2.0.)bicyclooctane derivatives with valuable therapeutic properties
AU1446192A (en) Process for the production of antibiotics, dna-sequences, recombinant-dna-constructs and microbial strains used therein
AU591091B2 (en) Pyrazolo 1,5-a-pyridin-3-yl or benzimidazol-2-yl derivatives
AU2681888A (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro- beta-carbolines
IT1207578B (it) Antibiotici carbapenem e relativo procedimento di preparazione.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)